Emerging new uses of phosphodiesterase-5 inhibitors in cardiovascular diseases

Phosphodiesterase type-5 (PDE-5) is an enzyme that catalyzes the hydrolytic degradation of cyclic GMP – an essential intracellular second messenger that modulates diverse biological processes in living cells. Three selective inhibitors of PDE-5 – sildenafil, vardenafil and tadalafil – have been succ...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kukreja, Rakesh C, Salloum, Fadi N, Das, Anindita, Koka, Saisudha, Ockaili, Ramzi A, Xi, Lei
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Pulsus Group Inc 2011
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3206106/
https://ncbi.nlm.nih.gov/pubmed/22131856
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak